News
27m
HealthDay on MSNEli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to Develop Heart DrugKey Takeaways Eli Lilly will acquire Verve for roughly $1 billionVerve is developing a one-time gene-editing treatment for ...
With backers such as Regeneron’s venture arm, Actio Biosciences is working on medicines that counter a wide range of ...
Eli Lilly's $1.3B acquisition of Verve Therapeutics caused a sharp rally, but with shares above the buyout price, I recommend ...
Asian shares are mixed and oil prices have advanced after the escalation of conflict in the Middle East hit Wall Street.
Streaming Finally Outpaces Traditional TV. The Leading Platform Might Surprise You. YouTube represented 12.5% of all television viewing in May-the highest share of TV for any streamer to date. The new ...
Another patient has died from acute liver failure after receiving Sarepta’s gene therapy for DMD ; After a quiet start to the ...
U.S. stocks slumped on Tuesday under the weight of another jump for the price of oil. It was a return to form for financial ...
Deputy DA Andrew Wood ruled Eric Salisbury's fatal shooting of Manuel Garza was justified self-defense, releasing bodycam ...
U.S. stocks slumped on Tuesday under the weight of another jump for the price of oil. It was a return to form for financial ...
NEW YORK (AP) — U.S. stock indexes are drifting lower on Tuesday, while oil prices rise again.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results